• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大型全国样本中脑静脉窦血栓形成的死亡率。

Mortality of cerebral venous-sinus thrombosis in a large national sample.

机构信息

Souers Stroke Institute, Department of Neurology, St Louis University, 1438 S Grand Boulevard, St Louis, MO 63104, USA.

出版信息

Stroke. 2012 Jan;43(1):262-4. doi: 10.1161/STROKEAHA.111.635664. Epub 2011 Oct 13.

DOI:10.1161/STROKEAHA.111.635664
PMID:21998058
Abstract

BACKGROUND AND PURPOSE

The purpose of this study was to evaluate the mortality rates associated with cerebral venous-sinus thrombosis in a large national sample.

METHODS

A cohort of patients with cerebral venous-sinus thrombosis was identified from the National Inpatient Sample database for the years 2000 to 2007. According to the International Classification of Diseases, 9th Revision, Clinical Modification codes, cerebral venous-sinus thrombosis is categorized into pyogenic and nonpyogenic groups. Multivariate logistic regression analysis was used to assess covariates associated with hospital mortality.

RESULTS

Among 3488 patients, the overall mortality rate was 4.39%, which was nonsignificantly higher among the pyogenic group (4.55% versus 3.52%; OR, 0.76; 95% CI, 0.47-1.23). In the pyogenic cerebral venous-sinus thrombosis group, hematologic disorders were the most frequent predisposing condition (16.2%); whereas systemic malignancy followed by hematologic disorders were most common in the nonpyogenic group (14.08% and 10.04%, respectively). Predictors of mortality included age, intracerebral hemorrhage as well as the predisposing conditions of hematologic disorders, systemic malignancy, and central nervous system infection.

CONCLUSIONS

Compared with arterial stroke, CVST harbors a relatively low mortality rate. Death is determined by age, the presence of intracerebral hemorrhage, and certain predisposing conditions.

摘要

背景与目的

本研究旨在评估大型国家样本中与脑静脉窦血栓形成相关的死亡率。

方法

从 2000 年至 2007 年的国家住院患者样本数据库中确定了脑静脉窦血栓形成患者队列。根据国际疾病分类,第 9 版修正临床修订版,脑静脉窦血栓形成分为化脓性和非化脓性两类。采用多变量逻辑回归分析评估与住院死亡率相关的协变量。

结果

在 3488 例患者中,总体死亡率为 4.39%,化脓性组略高(4.55%比 3.52%;OR,0.76;95%CI,0.47-1.23)。在化脓性脑静脉窦血栓形成组中,血液系统疾病是最常见的易患条件(16.2%);而非化脓性组中,全身性恶性肿瘤和血液系统疾病最常见(分别为 14.08%和 10.04%)。死亡的预测因素包括年龄、脑出血以及血液系统疾病、全身性恶性肿瘤和中枢神经系统感染等易患条件。

结论

与动脉性卒中相比,CVST 的死亡率相对较低。死亡取决于年龄、脑出血以及某些易患条件。

相似文献

1
Mortality of cerebral venous-sinus thrombosis in a large national sample.大型全国样本中脑静脉窦血栓形成的死亡率。
Stroke. 2012 Jan;43(1):262-4. doi: 10.1161/STROKEAHA.111.635664. Epub 2011 Oct 13.
2
Baseline Characteristics and Readmissions after Cerebral Venous Sinus Thrombosis in a Nationally Representative Database.全国代表性数据库中脑静脉窦血栓形成后的基线特征和再入院情况
Cerebrovasc Dis. 2018;46(5-6):249-256. doi: 10.1159/000495420. Epub 2019 Jan 2.
3
Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis.颅内静脉血栓形成患者的入院高血糖与临床转归
Stroke. 2016 Feb;47(2):390-6. doi: 10.1161/STROKEAHA.115.011177. Epub 2015 Dec 15.
4
[Clinical course of cerebral sinus venous thrombosis. Data from a monocentric cohort study over 15 years].[脑静脉窦血栓形成的临床病程。来自一项为期15年的单中心队列研究的数据]
Nervenarzt. 2014 Feb;85(2):211-20. doi: 10.1007/s00115-013-4000-8.
5
Association of admission clinical predictors and functional outcome in patients with Cerebral Venous and Dural Sinus Thrombosis.脑静脉和硬脑膜窦血栓形成患者入院临床预测因子与功能结局的相关性。
Clin Neurol Neurosurg. 2020 Jan;188:105563. doi: 10.1016/j.clineuro.2019.105563. Epub 2019 Nov 9.
6
Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States.儿童脑静脉窦血栓形成:来自美国的一项多中心队列研究
J Child Neurol. 2008 Jan;23(1):26-31. doi: 10.1177/0883073807307976.
7
Mortality in cerebral venous thrombosis: results from the national inpatient sample database.脑静脉血栓形成的死亡率:来自国家住院患者样本数据库的结果。
Cerebrovasc Dis. 2013;35(1):40-4. doi: 10.1159/000343653. Epub 2013 Feb 14.
8
Cerebral venous thrombosis: analysis of a multicenter cohort from the United States.脑静脉血栓形成:来自美国的多中心队列分析。
J Stroke Cerebrovasc Dis. 2008 Mar-Apr;17(2):49-54. doi: 10.1016/j.jstrokecerebrovasdis.2007.10.001.
9
Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study.脑静脉血栓形成的发病率和病死率:一项基于人群的研究。
Stroke. 2021 Nov;52(11):3578-3585. doi: 10.1161/STROKEAHA.121.034202. Epub 2021 Aug 10.
10
Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage.脑静脉血栓形成和脑出血患者预后的预测因素
Stroke. 2007 Feb;38(2):337-42. doi: 10.1161/01.STR.0000254579.16319.35. Epub 2007 Jan 4.

引用本文的文献

1
Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis-Where Do We Stand?直接作用口服抗凝剂在脑静脉窦血栓形成治疗中的应用现状如何?
Biomedicines. 2025 Jan 14;13(1):189. doi: 10.3390/biomedicines13010189.
2
Inpatient Outcomes of Cerebral Venous Thrombosis in Patients With Malignancy Throughout the United States.美国各地恶性肿瘤患者脑静脉血栓形成的住院结局
J Stroke. 2024 Sep;26(3):425-433. doi: 10.5853/jos.2023.04098. Epub 2024 Sep 13.
3
Cerebral Vein Thrombosis and Direct Oral Anticoagulants: A Review.
脑静脉血栓形成与直接口服抗凝剂:综述
J Clin Med. 2024 Aug 12;13(16):4730. doi: 10.3390/jcm13164730.
4
Spontaneous Intracranial Hypotension Discovered Following Cerebral Venous Thrombosis: A Case Report and Review of the Literature.脑静脉血栓形成后发现的自发性颅内低压:一例报告并文献复习
Cureus. 2024 Jun 22;16(6):e62884. doi: 10.7759/cureus.62884. eCollection 2024 Jun.
5
Case report: cerebral venous sinus thrombosis and pulmonary embolism as the initial presentation in a child with asymptomatic primary nephrotic syndrome.病例报告:一名患有无症状原发性肾病综合征的儿童以脑静脉窦血栓形成和肺栓塞为首发表现。
Front Pediatr. 2023 May 5;11:1169116. doi: 10.3389/fped.2023.1169116. eCollection 2023.
6
Diagnostic and Therapeutic Challenges of Concurrent Intracranial Hemorrhage and Cerebral Venous Thrombosis in a Patient With Acute Lymphoblastic Leukemia: A Case Report and Literature Review.急性淋巴细胞白血病患者并发颅内出血和脑静脉血栓形成的诊断与治疗挑战:一例报告及文献综述
Cureus. 2023 Apr 12;15(4):e37482. doi: 10.7759/cureus.37482. eCollection 2023 Apr.
7
ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine.ChAdOx1 nCoV-19阿斯利康新冠疫苗。
JRSM Cardiovasc Dis. 2023 Apr 11;12:20480040231169464. doi: 10.1177/20480040231169464. eCollection 2023 Jan-Dec.
8
Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder.疫苗诱导的免疫性血栓性血小板减少症的独特特征;一种新的抗血小板因子 4 抗体介导的疾病。
Int J Hematol. 2023 Mar;117(3):341-348. doi: 10.1007/s12185-022-03516-4. Epub 2022 Dec 27.
9
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score.脑静脉血栓形成的预后预测:IN-REvASC评分
J Stroke. 2022 Sep;24(3):404-416. doi: 10.5853/jos.2022.01606. Epub 2022 Sep 30.
10
Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019.2018年和2019年美国脑静脉窦血栓形成及合并血小板减少的脑静脉窦血栓形成的流行病学
Res Pract Thromb Haemost. 2022 Mar 7;6(2):e12682. doi: 10.1002/rth2.12682. eCollection 2022 Feb.